NSEOutcome of Board Meeting21h ago · 30 Oct 2026, 05:45 pm

Outcome of Board Meeting

Artemis Medicare Services Limited · ARTEMISMED

✦ AI SummaryResults

Artemis Medicare Services Limited has submitted its un-audited financial results for the quarter ended September 30, 2026, with the Board of Directors approving the results at its meeting held on October 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Artemis Medicare Services Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Attachments (1)

📄

ARTEMISMED_30102026174453_Outcome_of_BM_October_2026.pdf

pdf

Download →
View document text
OUR ♦ SPECIALITY IS NABH & JCI Accredited ♦ H 0 s p T A L s YOU ♦ A unit of Artemis Medicare Services Ltd. www.artemishospitals.com October 30, 2026 Listing Department, Listing Department, National Stock Exchange of India Limited BSE Limited Exchange Plaza, Bandra-Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Dalal Street, Mumbai – 400 051 Mumbai – 400 001 NSE Symbol: ARTEMISMED Scrip Code: 542919 Dear Sir/Madam, Sub: Outcome of Board Meeting held on October 30, 2026 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we wish to inform you that the Board of Directors at its meeting held today, inter- alia, approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter/ half year ended September 30, 2026. Pursuant to Regulation 33 of SEBI Listing Regulations, please find enclosed herewith the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter/ half year ended September 30, 2026 alongwith limited review reports for the said period issued by the Statutory Auditors of the Company. In terms of Regulation 47 of SEBI Listing Regulations, the extract of the Un-audited Consolidated Financial Results for the quarter/ half year ended September 30, 2026, along with the Quick Response (QR) code and the details of the webpage where the complete financial results are accessible, shall be published in the newspapers. The full format of the financial results shall be available on the website of the Stock Exchanges where equity shares of the Company are listed i.e. www.nseindia.com and www.bseindia.com and on Company’s website www.artemishospitals.com. The meeting of the Board of Directors commenced at 4:00 PM and concluded at 5:00 PM. You are requested to take the same on your record. Thanking you, Yours faithfully, For Artemis Medicare Services Limited Poonam Makkar Company Secretary & Compliance Officer Encl.: As above ARTEMIS Artemis Medicare Services Ltd. PHRAPP Corporate Office: Sector 51, Gurugram -122001, Haryana, lndia ARTEMIS VENT\JRES Ph.: +91-124-4511111 I Emergency & Trauma: +91-124-4588 888 I Fa•: +91-124-4588 899 Registered Office: Plot No. 14, Sector 20, Dwarka, New Delhi -110075 I CIN: L85110DL2004PLC126414 J GST: 06AAFCA0130M1Zl (HR), 07AAFCA0130M1ZZ (DEL) I TAN: DELA16048E J PAN: AAFCA0130M J Email: info@artemishospitals.com I Web: www.artemishospitals.com CA T R Chadha & Co LLP IND I A --=== Chartered Accountants ==-- Independent Auditor’s Review Report on Review of Quarterly and Half Yearly Unaudited Standalone Financial Results of Artemis Medicare Services Limited Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended The Board of Directors Artemis Medicare Services Limited 1. We have reviewed the accompanying Statement of Standalone Unaudited Financial Results of Artemis Medicare Services Limited (“the Company”) for the quarter and half year ended September 30, 2026, (hereinafter referred to as “the Statement”), being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended to date (“Listing Regulations”). 2. The Statement, which is the responsibility of the Company’s Management and approved by the Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 (Ind AS 34) “Interim Financial Reporting” prescribed under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity', issued by the Institute of Chartered Accountants of India (ICAI). This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of the Company's personnel responsible for financial and accounting matters and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Companies Act, 2013 and consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted and procedures performed as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in all material respects in accordance with applicable Indian Accounting Standards prescribed under Section 133 of the Companies Act, 2013, read with relevant rules issued thereunder, and other recognized accounting practices and policies, has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. For T R Chadha & Co LLP Chartered Accountants (Firm Regn. No. 006711N/N500028) Name: Neena Goel Partner Membership Number: 057986 Place of signature: Noida Date: October 30, 2026 UDIN: 26057986DBOVSS8536 T R Chadha & Co LLP, A limited liability partnership with LLP Identification No. AAF-3926 Noida Branch Office: Plot No. B-13, First Floor, Sector-1, Noida- 201301, Gautam Budh Nagar (U.P.) | Ph: +91 120 4499900 E mail: noida@trchadha.com; Corporate/ Regd. Office: B-30, Connaught Place, Kuthiala Building, New Delhi – 110001 | Ph: +91 011 43259900 | E-mail: delhi@trchadha.com Offices: Ahmedabad | Bengaluru | Chennai | Gurugram | Hyderabad | Mumbai | New Delhi | Noida | Pune | Tirupati | Vadodara www.trchadha.com ARTEMIS MEDICARE SERVICES LIMITED CIN: L85110DL2004PLC126414 Registered office: Plot No.14, Sector 20, Dwarka, South West Delhi, Delhi-110075 Ph.: +91-124-4511111; Email: investor@artemishospitals.com; Website: www.artemishospitals.com STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER AND SIX MONTHS ENDED SEPTEMBER 30, 2026 (flnLacs) Quarter ended Six Months ended I Year ended SNo. Particulars 30-Sep-26 I 30-Jun-26 I 30-Sep-25 30-Sep-26 30-Sep-25 I 31-Mar-26 (Unaudited) I (Audited) 1. Income (a) Revenue from Operations 30,570.62 28,200.97 26,978.31 58,771.59 51,958.17 1,06,049.17 (b) Other Income 817.94 539.58 778.35 1,357.52 1,474.11 2,990.48 Total Income 31,388.56 28,740.55 27,756.66 60,129.11 53,432.28 1,09,039.65 2. Expenses (a) Operative Expenses 18,881.49 16,519.05 16,285.91 35,400.54 31,730.47 64,091.48 (b) Employee Benefits Expense 4,299.74 4,175.93 3,825.42 8,475.67 7,556.07 16,183.67 (c) Finance Costs 738.79 642.20 693.42 1,380.99 1,404.34 2,694.40 (d) Depreciation and Amortization Expense 1,412.18 1,235.28 1,123.89 2,647.46 2,189.88 4,632.79 (e) Other Expenses 1,980.08 1,957.11 1,851.15 3,937.19 3,567.94 7,261.42 Total Expenses 27,312.28 24,529.57 23,779.79 51,841.85 46,448.70 94,863.76 3. Profit before exceptional items and tax (1-2) 4,076.28 4,210.98 3,976.87 8,287.26 6,983.58 14,175.89 4. Exceptional Items (Impact of Labour Code) 307.44 5. Profit before tax (3-4) 4,076.28 4,210.98 3,976.87 8,287.26 6,983.58 13,868.45 6. Tax Expense: (a) Current Tax 867.98 1,004 04 821.67 1,872.02 1,494.49 2,916.95 (b) Earlier Year Tax (13.83) (c) Deferred Tax Charge/ (Credit) 112.99 101.83 158.75 214.82 350.92 621.18 Total Tax Expense 980.97 1,105.87 980.42 2,086.84 1,845.41 3,524.30 [Showing first 8,000 characters — download PDF for full document]